SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotime-Nasdaq's best kept secret?
BTIM 0.00010000.0%Nov 5 1:26 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Roof who wrote (809)4/2/1998 5:40:00 AM
From: Stephen How  Read Replies (1) of 1432
 
An estimate of annual U.S. starch-based plasma expander usage based on Canadian Pentastarch usage

If it's true that Canada uses pentastarch as it's exclusive starch-based plasma expander, we should be able to extrapolate the annual U.S. starch + albumin usage from their data. (I guess the Canadian numbers are available because of their centralized Red Cross blood banking.)

I found an estimate of the 1994 Canadian pentastarch usage at 360,000 units/year = 180,000 liters/year.

(http://doyle.ibme.utoronto.ca/anesthesia/Penta4.HTM)

Scaling this usage by the U.S./Canadian population ratio of 250M/30M, we get a rough estimate of

U.S. starch-based expander usage =~ 1.5M liters/year

Using the price of Hespan from $36 - $60 per liter, as gleaned from the S.F. Chronicle (Herb Greenberg 10/9/97):

-- Point of order: An item here earlier this week regarding Berkeley-based Biotime said that a blood-volume expander sold by rival DuPont costs between $20 and $50 per liter; make that $36 to $60. A DuPont spokesman says most hospitals have contracts to buy the product at the very low end of the range.


we get an annual U.S. market of $54M - $90M /year.

YMMV,
Steve

btim.dyn.ml.org
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext